Strides Pharma [STAR] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison
Strides Pharma
NSE
Loading...
Divi's Laboratories
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Strides Pharma wins in 10 metrics, Divi's Laboratories wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Strides Pharma | Divi's Laboratories | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 21.59 | 70.40 | Strides Pharma |
| Price-to-Book Ratio | 2.89 | 10.87 | Strides Pharma |
| Debt-to-Equity Ratio | 72.67 | 0.03 | Divi's Laboratories |
| PEG Ratio | 12.43 | 108.91 | Strides Pharma |
| EV/EBITDA | 11.75 | 51.98 | Strides Pharma |
| Profit Margin (TTM) | 7.38% | 23.89% | Divi's Laboratories |
| Operating Margin (TTM) | 15.11% | 25.60% | Divi's Laboratories |
| EBITDA Margin (TTM) | 15.11% | 25.60% | Divi's Laboratories |
| Return on Equity | 138.93% | 14.64% | Strides Pharma |
| Return on Assets (TTM) | 59.41% | 12.94% | Strides Pharma |
| Free Cash Flow (TTM) | $4.42B | $2.15B | Strides Pharma |
| Dividend Yield | 0.74% | 0.91% | Divi's Laboratories |
| 1-Year Return | -29.61% | 22.45% | Divi's Laboratories |
| Price-to-Sales Ratio (TTM) | 1.59 | 16.86 | Strides Pharma |
| Enterprise Value | $92.90B | $1,593.02B | Divi's Laboratories |
| EV/Revenue Ratio | 2.01 | 16.51 | Strides Pharma |
| Gross Profit Margin (TTM) | 60.32% | 60.33% | Divi's Laboratories |
| Revenue per Share (TTM) | $503 | $363 | Strides Pharma |
| Earnings per Share (Diluted) | $37.06 | $87.10 | Divi's Laboratories |
| Beta (Stock Volatility) | 0.57 | 0.27 | Divi's Laboratories |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Strides Pharma vs Divi's Laboratories Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Strides Pharma | 0.76% | -3.84% | -7.07% | 26.63% | 9.57% | 14.21% |
| Divi's Laboratories | -3.54% | -7.03% | -14.75% | -0.77% | -0.41% | -2.61% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Strides Pharma | -29.61% | 130.32% | 44.47% | -33.73% | 100.09% | 182.26% |
| Divi's Laboratories | 22.45% | 58.73% | 91.42% | 441.88% | 1,482.26% | 9,037.19% |
Performance & Financial Health Analysis: Strides Pharma vs Divi's Laboratories
| Metric | STAR | DIVISLAB |
|---|---|---|
| Market Information | ||
| Market Cap | ₹73.74B | ₹1.63T |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 645,887 | 416,189 |
| 90 Day Avg. Volume | 533,103 | 360,518 |
| Last Close | ₹804.40 | ₹5,914.50 |
| 52 Week Range | ₹513.05 - ₹1,675.00 | ₹4,615.55 - ₹7,071.50 |
| % from 52W High | -51.98% | -16.36% |
| All-Time High | ₹1,675.00 (Oct 14, 2024) | ₹7,071.50 (Jul 08, 2025) |
| % from All-Time High | -51.98% | -16.36% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.03% | 0.14% |
| Quarterly Earnings Growth | 0.42% | 0.27% |
| Financial Health | ||
| Profit Margin (TTM) | 0.07% | 0.24% |
| Operating Margin (TTM) | 0.15% | 0.26% |
| Return on Equity (TTM) | 1.39% | 0.15% |
| Debt to Equity (MRQ) | 72.67 | 0.03 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹276.88 | ₹563.87 |
| Cash per Share (MRQ) | ₹21.55 | ₹132.86 |
| Operating Cash Flow (TTM) | ₹36.02B | ₹19.67B |
| Levered Free Cash Flow (TTM) | ₹35.93B | ₹21.91B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.74% | 0.91% |
| Last 12-Month Dividend | ₹6.50 | ₹60.00 |
Valuation & Enterprise Metrics Analysis: Strides Pharma vs Divi's Laboratories
| Metric | STAR | DIVISLAB |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 21.59 | 70.40 |
| Forward P/E | 12.43 | 108.91 |
| PEG Ratio | 12.43 | 108.91 |
| Price to Sales (TTM) | 1.59 | 16.86 |
| Price to Book (MRQ) | 2.89 | 10.87 |
| Market Capitalization | ||
| Market Capitalization | ₹73.74B | ₹1.63T |
| Enterprise Value | ₹92.90B | ₹1.59T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.01 | 16.51 |
| Enterprise to EBITDA | 11.75 | 51.98 |
| Risk & Other Metrics | ||
| Beta | 0.57 | 0.27 |
| Book Value per Share (MRQ) | ₹276.88 | ₹563.87 |
Financial Statements Comparison: Strides Pharma vs Divi's Laboratories
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | STAR | DIVISLAB |
|---|---|---|
| Revenue/Sales | ₹11.20B | ₹24.10B |
| Cost of Goods Sold | ₹4.44B | ₹9.56B |
| Gross Profit | ₹6.75B | ₹14.54B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹1.69B | ₹6.17B |
| EBITDA | ₹2.27B | ₹8.48B |
| Pre-Tax Income | ₹1.22B | ₹7.33B |
| Income Tax | ₹164.50M | ₹1.88B |
| Net Income (Profit) | ₹1.06B | ₹5.45B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | STAR | DIVISLAB |
|---|---|---|
| Cash & Equivalents | ₹1.13B | ₹4.15B |
| Total Current Assets | ₹31.02B | ₹100.81B |
| Total Current Liabilities | ₹25.92B | ₹14.52B |
| Long-Term Debt | ₹6.23B | ₹20.00M |
| Total Shareholders Equity | ₹25.86B | ₹149.69B |
| Retained Earnings | ₹4.59B | ₹134.00B |
| Property, Plant & Equipment | ₹8.81B | ₹3.19B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | STAR | DIVISLAB |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | STAR | DIVISLAB |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 645,887 | 416,189 |
| Average Daily Volume (90 Day) | 533,103 | 360,518 |
| Shares Outstanding | 92.16M | 265.47M |
| Float Shares | 58.68M | 120.74M |
| % Held by Insiders | 0.33% | 0.52% |
| % Held by Institutions | 0.25% | 0.29% |
Dividend Analysis & Yield Comparison: Strides Pharma vs Divi's Laboratories
| Metric | STAR | DIVISLAB |
|---|---|---|
| Last 12-Month Dividend | ₹6.50 | ₹60.00 |
| Last 12-Month Dividend Yield | 0.74% | 0.91% |
| 3-Year Avg Annual Dividend | ₹2.67 | ₹50.00 |
| 3-Year Avg Dividend Yield | 0.32% | 0.70% |
| 3-Year Total Dividends | ₹8.00 | ₹150.00 |
| Ex-Dividend Date | Jul 22, 2025 | Jul 25, 2025 |